How to bid on a Laser Capture Microdissection Microscope System for NIH

What the agency is buying

The National Institutes of Health (NIH) is looking to acquire one Accuva Cellect Laser Capture Microdissection (LCM) system from Laxco, Inc. This system includes necessary software, equipment, installation, training, and support. The NIH needs this specific system to support its ongoing laser capture microdissection research activities. The Accuva Cellect LCM is required because it offers specialized capabilities for complex microdissection tasks, including managing many regions of interest, advanced freehand markup editing, and selective capture and cutting of objects.

This opportunity is initially planned as a sole-source award to Laxco, Inc. However, the NIH is open to considering other vendors. If your company can provide a system that meets all the specified technical requirements, you are encouraged to submit a capability statement.

Key dates and deadlines

The deadline for submitting capability statements is September 21, 2026, at 9:00 AM ET. All responses must be submitted electronically by this time. The NIH anticipates making an award approximately five calendar days after this closing date, unless another responsible source is identified.

Who this opportunity suits

This opportunity is suitable for vendors who can supply advanced laboratory equipment, specifically laser capture microdissection systems. Your firm should be capable of providing a system that precisely matches the technical requirements outlined by the NIH, including large-scale region of interest management, advanced freehand markup editing, selective object and group capture, retention of complex markups, system stability during complex workflows, and compatibility with established research protocols based on the Arcturus XT LCM platform. This is a highly specialized equipment procurement.

How to respond

To respond to this solicitation, you must submit a capability statement. This statement should clearly demonstrate your ability to provide the required Accuva Cellect LCM system and meet all the specified technical and operational requirements. Your capability statement must be sent electronically to [email protected]. Remember to reference Notice No. 75N98026Q01125 in the subject line of your email.

Practical tips for your response

When preparing your capability statement, focus on directly addressing each of the technical requirements listed by the NIH. Provide specific details on how your proposed system meets or exceeds each capability, such as large-scale ROI management, advanced freehand markup editing, and workflow compatibility. Avoid general statements; instead, offer concrete examples or specifications.

Ensure your submission is concise, clear, and easy to understand. Double-check that all required information is included and that your email is sent to the correct address before the deadline. A well-organized and detailed response will help the NIH determine if your firm is a responsible source capable of meeting their needs.